Blacks, Hispanics More Likely to Report Long COVID Symptoms

May 1, 2023 by Dan McCue
Blacks, Hispanics More Likely to Report Long COVID Symptoms
(US Census Bureau photo)

WASHINGTON — Black and Hispanic respondents were more likely than other racial or ethnic groups to report COVID-19 symptoms lasting three months or longer, according to a new Household Pulse Survey conducted by the U.S. Census Bureau.

The Household Pulse Survey, an experimental online survey representative of the U.S. adult population at the state and national level, began asking about long COVID symptoms in June 2022, more than two years after the pandemic hit the United States. 

It found that 31.1% of respondents aged 18 and over reported long-lasting symptoms.

Respondents were asked if they had ever tested positive for or had been told by a health care provider that they had COVID-19. Respondents who answered “yes” were then asked if they had symptoms they did not have pre-COVID-19 that they still experienced at least three months later.

The HPS data tool allows users to explore a number of different national, state and metro area estimates, including the percentage of adults who experienced long COVID symptoms.

Who Suffers Long COVID?

Hispanic respondents were the most likely to report long COVID symptoms and non-Hispanic Asian respondents were the least likely.

Though less likely than Hispanic respondents, Black respondents were more likely than White or Asian respondents to suffer long COVID.

Women were more likely than men to say they suffered long-lasting symptoms.

But respondents who identified as “Transgender” or “None of these” listed genders were far more likely to suffer from long COVID than those identifying as male or female.

Respondents identifying as gay/lesbian or straight were the least likely to suffer from long COVID symptoms and were not statistically different from one another.

People between ages 40 and 59 were the most likely to report long COVID symptoms, while those in the oldest age category (70 and over) were the least likely.

Does Long COVID Vary by Education and Income?

Respondents without a high school degree were the most likely to report long COVID symptoms while those with a college degree were the least likely.

Those with a high school degree or less were the least likely to report having tested positive for COVID-19 while those with at least some college were the most likely.

When it came to income comparisons, the researchers limited themselves to asking questions of two-adult/two-children households.

Not all estimates were significantly different but it is clear that those at the top income distribution (more than $100,000) were less likely than those at the bottom (less than $100,000) to report long COVID. 

Approximately 27% of long COVID sufferers were financially insecure, compared to 18% of people who never tested positive for COVID-19, and 15% of people who did but did not have long COVID symptoms. 

Respondents reporting they never tested positive for COVID-19 actually faced higher levels of hardship than those who did test positive but reported no long-lasting symptoms.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • Census Bureau
  • COVID-19
  • health
  • Long COVID
  • In The News

    Health

    Voting

    Health

    April 18, 2024
    by Beth McCue
    Salmonella Outbreak Linked to Fresh Basil 

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic... Read More

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic basil. As of the alert, 12 Salmonella cases in seven states have been reported. There are no reported deaths. The basil was sold at Trader Joe’s... Read More

    April 17, 2024
    by Dan McCue
    Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

    Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

    Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

    April 16, 2024
    by Dan McCue
    Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

    Biden Administration Announces Partnership With 50 Countries to Stifle Future Pandemics

    WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal... Read More

    WASHINGTON (AP) — President Joe Biden's administration will help 50 countries identify and respond to infectious diseases, with the goal of preventing pandemics like the COVID-19 outbreak that suddenly halted normal life around the globe in 2020. U.S. government officials will work with the countries to develop better testing, surveillance,... Read More

    News From The Well
    scroll top